"L’Hôpital privé Arras les Bonnettes, situé sur la commune d’Arras, né de la fusion des cliniques Bon-Secours et Sainte-Catherine, a rejoint le groupe Ramsay Santé au milieu des années 2000. Acteur majeur de la santé de la région des Hauts de France, l’établissement a inauguré en 2007 un nouveau bâtiment disposant de 284 lits. Il dispose d’un bloc opératoire de 15 salles et d’une maternité.110 médecins et 400 soignants paramédicaux y exercent."

During the past decade, Hôpital privé Arras les Bonnettes conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital privé Arras les Bonnettes" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 2 trials, followed by "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials sponsored, "Fadoi Foundation, Italy" with 1 trials sponsored, "Ramsay Générale de Santé" with 1 trials sponsored and "UNICANCER" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital privé Arras les Bonnettes" #1 collaborator was "Amgen" with 1 trials as a collaborator, "European Clinical Trial Experts Network" with 1 trials as a collaborator, "Servier" with 1 trials as a collaborator and "University of Perugia, Italy" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital privé Arras les Bonnettes" are "Anesthesia" (1 trials), "Chemotherapy-induced Anemia" (1 trials), "Chemotherapy-induced Febrile Neutropenia (FN)" (1 trials), "Colonic Adenocarcinoma" (1 trials) and "Esophagus Adenocarcinoma" (1 trials). Many other conditions were trialed in "Hôpital privé Arras les Bonnettes" in a lesser frequency.

Most popular intervention types in "Hôpital privé Arras les Bonnettes" are "Drug" (3 trials), "Behavioral" (1 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Dalteparin" (1 trials), "FOLFOX + panitumumab" (1 trials), "FOLFOX regimen" (1 trials) and "FOLFOX4 or XELOX" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital privé Arras les Bonnettes" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital privé Arras les Bonnettes". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hôpital privé Arras les Bonnettes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital privé Arras les Bonnettes, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".